Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.
Cecilia Monge BonillaChangqing XieYuta MyojinKelley L Coffman-D'AnnibaleDonna HronesGagandeep BrarSophie WangAnuradha BudhuWilliam D FiggMaggie CamRichard FinneyElliot B LevyDavid E KleinerSeth M SteinbergXin Wei WangBernadette ReddBradford J WoodTim F GretenPublished in: Cancer medicine (2024)
Durva/Treme and Durva/Treme + IR showed similar efficacy. With a manageable safety profile. Larger studies are needed to fully characterize the efficacy of Durva/Treme ± IR in advanced BTC.
Keyphrases